FI885177A - FOERFARANDE FOER BEHANDLING AV LEUKEMIER OCH VISSA ANDRA FORMER AV CANCER. - Google Patents

FOERFARANDE FOER BEHANDLING AV LEUKEMIER OCH VISSA ANDRA FORMER AV CANCER. Download PDF

Info

Publication number
FI885177A
FI885177A FI885177A FI885177A FI885177A FI 885177 A FI885177 A FI 885177A FI 885177 A FI885177 A FI 885177A FI 885177 A FI885177 A FI 885177A FI 885177 A FI885177 A FI 885177A
Authority
FI
Finland
Prior art keywords
leukemier
vissa
andra
och
cancer
Prior art date
Application number
FI885177A
Other languages
Finnish (fi)
Other versions
FI885177A0 (en
Inventor
Mikael Jondal
Anders Rosen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI885177A0 publication Critical patent/FI885177A0/en
Publication of FI885177A publication Critical patent/FI885177A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2033—IL-5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI885177A 1987-03-11 1988-11-10 FOERFARANDE FOER BEHANDLING AV LEUKEMIER OCH VISSA ANDRA FORMER AV CANCER. FI885177A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8701004A SE8701004D0 (en) 1987-03-11 1987-03-11 METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES
PCT/SE1988/000118 WO1988006891A1 (en) 1987-03-11 1988-03-10 Method for therapy of leukemias and certain other malignancies

Publications (2)

Publication Number Publication Date
FI885177A0 FI885177A0 (en) 1988-11-10
FI885177A true FI885177A (en) 1988-11-10

Family

ID=20367826

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885177A FI885177A (en) 1987-03-11 1988-11-10 FOERFARANDE FOER BEHANDLING AV LEUKEMIER OCH VISSA ANDRA FORMER AV CANCER.

Country Status (6)

Country Link
EP (1) EP0305468A1 (en)
JP (1) JPH01502592A (en)
AU (1) AU621046B2 (en)
FI (1) FI885177A (en)
SE (1) SE8701004D0 (en)
WO (1) WO1988006891A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
GB8808015D0 (en) 1988-04-06 1988-05-05 Ritter M A Chemical compounds
EP0454736A4 (en) * 1989-01-20 1993-05-12 The University Of Melbourne Fibrinolysis
JP2704546B2 (en) * 1989-04-04 1998-01-26 光利 太良 ATLL therapeutic inhalant
KR100191223B1 (en) * 1989-07-28 1999-06-15 둘락 노먼 씨. Method for purifying interleukin-4 and pharmaceutical composition comprising them
FR2653020B1 (en) * 1989-10-17 1993-03-26 Roussel Uclaf USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEUKEMIA.
GB9001625D0 (en) * 1990-01-24 1990-03-21 Ciba Geigy Ag A pharmaceutical preparation for maturation of prothymocytes
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
WO1992008792A2 (en) * 1990-11-16 1992-05-29 Schering Corporation Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5
MX9205233A (en) * 1991-09-16 1993-12-01 Schering Corp USE OF IL-5 TO TREAT SOLID TUMORS.
PT751781E (en) * 1993-12-23 2004-09-30 Nat Inst Of Health As Repr By USE OF MONOCLONAL ANTIBODIES OR OLIGOMERIC LIGANDS SOLUABLE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION OR TREATMENT OF NEOPLASTIC DISORDERS
US7033589B1 (en) 1997-02-20 2006-04-25 Biogen Idec Ma Inc. γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US6893636B2 (en) 1997-02-20 2005-05-17 Biogen Idec Ma Inc. Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US11497781B2 (en) 2016-03-10 2022-11-15 Cg Oncology, Inc. Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077571A3 (en) * 1981-10-19 1983-10-12 Ajinomoto Co., Inc. Process for producing a lymphokine
JPH0637520B2 (en) * 1985-07-03 1994-05-18 味の素株式会社 Polypeptide
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
JPH0763361B2 (en) * 1985-10-15 1995-07-12 三井東圧化学株式会社 Cultured cell line
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
EP0256042A1 (en) * 1986-01-15 1988-02-24 AMERSHAM INTERNATIONAL plc Interleukin
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent

Also Published As

Publication number Publication date
SE8701004D0 (en) 1987-03-11
FI885177A0 (en) 1988-11-10
AU621046B2 (en) 1992-03-05
JPH01502592A (en) 1989-09-07
AU1487888A (en) 1988-10-10
WO1988006891A1 (en) 1988-09-22
EP0305468A1 (en) 1989-03-08

Similar Documents

Publication Publication Date Title
FI844753A0 (en) RECEPTORSYSTEM FOER CELLMATRIS OCH ANVAENDNING DAERAV FOER DIAGNOSTICERING OCH BEHANDLING AV CANCER.
FI882827A0 (en) FOERFARANDE OCH ANORDNING FOR FRAMSTAELLNING AV BURKAEMNE AV STYMPAD PYRAMIDFORM.
FI885177A (en) FOERFARANDE FOER BEHANDLING AV LEUKEMIER OCH VISSA ANDRA FORMER AV CANCER.
FI870979A (en) FILTERKONSTRUKTION OCH FOERFARANDE FOER BILDANDE AV FILTERKONSTRUKTION.
FI890645A (en) KLONING OCH EXPRESSION AV MAENNISKANS VAEVNADSFAKTOR.
FI871274A (en) FOERFARANDE OCH ANORDNING FOER STYRNING AV BERGBORRNING.
FI87024B (en) FOERFARANDE FOER STYRNING AV EN KORTSLUTEN ASYNKRONMOTOR OCH STYRKRETS.
FI870184A0 (en) AKUSTISKT STROEMNINGSMAETNINGSFOERFARANDE OCH ANORDNING FOER TILLAEMPNING AV DETTA.
FI871739A (en) FOERFARANDE OCH ANORDNING FOER AOTSKILJNING AV VAETSKOR.
FI852329L (en) FOERFARANDE FOER FRAMSTAELLNING AV BESKIKTNINGSMEDEL FOER PAPPER OCH ANDRA CELLULOSAHALTIGA AEMNEN.
FI871034A (en) FOERFARANDE OCH ANORDNING FOER UPPSTAPLING AV CELLULOSABALAR.
FI884369A (en) FOERFARANDE FOER TERMISK KRACKNING OCH ANDRA VAETSKA / -GASREAKTIONER AV KOLVAETEOLJOR.
FI894313A (en) FOERFARANDE FOER TERMISK KRACKNING AV KOLVAETEOLJOR OCH FOER ANDRA VAETSKE / -GASREAKTIONER.
FI80863B (en) FOERFARANDE OCH ANORDNING FOER LAGRING AV PAPPERSRULLAR.
FI870508A0 (en) ACCELERATIONSMUNSTYCKE OCH FOERFARANDE FOER FRAMSTAELLNING AV DETSAMMA.
FI870632A0 (en) TRAENINGS- OCH TERAPIMEDEL OCH ANVAENDNING AV DETTA.
FI870339A (en) BROTTSENSOR OCH FOERFARANDE FOER FRAMSTAELLNING AV DENSAMMA.
FI870878A0 (en) FOERFARANDE OCH ANORDNING FOER BEGRAENSNING AV DJURS ROERELSE.
FI870943A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV RAKA KANALDELAR OCH EN KANALDEL.
FI870124A0 (en) VAERMEACKUMULATOR FOER UNDERLAETTAD KALLSTART OCH FOERVAERMNING AV VAETSKEKYLDA FORDON.
FI870183A0 (en) FOERFARANDE OCH ANORDNING FOER SKALNING AV LAONGSTRAECKTA OSKALADE STYCKEN.
FI871002A0 (en) FOERFARANDE OCH ANORDNING FOER BELAEGGNING AV MATERIALBANA.
FI871518A0 (en) SYRAKATALYSATORER OCH ANVAENDNING AV DESSA.
FI871020A0 (en) FOERFARANDE OCH ANORDNING FOER UPPSAMLING AV OLJA.
FI871391A0 (en) FOERFARANDE FOER REGLERING AV EN VENTILATIONSKANAL OCH ANORDNING FOER FOERFARANDETS GENOMFOERANDE.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: AKTIEBOLAGET ASTRA